Skip to content
Open access

Multi-national evaluation of low-density lipoprotein cholesterol equations in young adulthood for long-term risk of atherosclerotic cardiovascular disease

Sep 2026 · Circulation. Population health and outcomes · pp. e013678 - e013678 · 1 citation · 30 references
Medicine

TL;DR

The Martin-Hopkins equation provides more accurate LDL-C–based risk classification, identifying high-risk young adults missed by other equations and minimizing misclassification of those at normal risk.

Abstract

Background Accurate low-density-lipoprotein-cholesterol (LDL-C) assessment in young adulthood is critical for atherosclerotic cardiovascular disease (ASCVD) prevention, yet the optimal estimation equation remains uncertain. We compared the Friedewald, Martin-Hopkins, and Sampson equations for evaluating long-term ASCVD risks. Methods We included participants from 7 population-based cohorts within the International Childhood Cardiovascular Cohort Consortium who had LDL-C measurements in young adulthood (aged 20–39 years) and follow-up data for incident ASCVD. LDL-C levels were estimated using the Friedewald, Martin-Hopkins, Sampson equations. For each pair of equations, participants were categorized into concordant (normal/normal, elevated/elevated) and discordant (normal/elevated, elevated/normal) groups based on LDL-C classifications (normal <130 mg/dL versus elevated ≥130 mg/dL). ASCVD events (myocardial infarction, stroke, transient ischemic attack, ischemic heart failure, angina, peripheral artery disease, carotid intervention, abdominal aortic aneurysm, coronary revascularization) were adjudicated from medical records. Associations between discordance and incident ASCVD were estimated using Fine-Gray regressions. Results Among 10550 participants [56.8% females; mean baseline age (standard deviation), 29.8 (4.3) years], 376 ASCVD events occurred over a mean follow-up of 22.7 years. Elevated LDL-C by all equations was associated with ASCVD events [sub-distribution hazards ratio (95% confidence interval): Martin-Hopkins, 1.69 (1.35–2.12); Sampson, 1.52 (1.22–1.90); Friedewald, 1.47 (1.17–1.84)]. Total discordance ranged from 2.3% to 2.9%. Compared with concordant normal LDL-C group, normal LDL-C by Friedewald but elevated by Martin-Hopkins had higher ASCVD risks [3.32 (1.94–5.66)], with no excess risk in the reverse discordance [1.19 (0.47–3.05)]. Normal Friedewald but elevated Sampson LDL-C had higher ASCVD risks [1.69 (0.93–3.05)]; no participants had the reverse discordance. Normal Sampson LDL-C but elevated Martin-Hopkins LDL-C had higher ASCVD risks [3.94 (1.80–8.64)], whereas the reverse discordance showed no increased risk [0.86 (0.39–1.91)]. Conclusions The Martin-Hopkins equation provides more accurate LDL-C–based risk classification, identifying high-risk young adults missed by other equations and minimizing misclassification of those at normal risk.

Read PDF

Similar papers

Open access Sep 2026

Estimated small dense low-density lipoprotein cholesterol in predicting atherosclerotic cardiovascular disease: Longitudinal evidence from over 1 million Japanese adults.

BACKGROUND Small dense low-density lipoprotein cholesterol (sdLDL-C) is an atherogenic LDL-C subfraction associated with atherosclerotic cardiovascular disease (ASCVD). Although sdLDL-C integration into major routine risk assessments remains limited, partly because of requiring additional lipid tests, a more implementa...

Koki Ono, A. Hirata, T. Okamura · 0 citations
Review Open access Sep 2026

Residual Apolipoprotein B Elevation Despite PREVENT-Guided LDL-C Goal Attainment Among Adults Without Known ASCVD.

BACKGROUND Low-density lipoprotein cholesterol (LDL-C) goal attainment is central to primary atherosclerotic cardiovascular disease (ASCVD) prevention, but LDL-C may not fully reflect the burden of apolipoprotein B (ApoB)-containing atherogenic particles. The prevalence and clinical correlates of residual ApoB elevatio...

Yan-Ping Shi, Yuan Tang, Meng-Ting Wang et al. · 0 citations
Open access Sep 2026

Lipoprotein(a) identifies premature coronary artery disease in patients with low LDL-cholesterol: A large multicenter cohort study.

BACKGROUND Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease. Whether elevated Lp(a) is associated with premature coronary artery disease (pCAD) in young and middle-aged adults with low levels of low-density lipoprotein cholesterol (LDL-C) remains poorly c...

Y. Bawahab, V. Vasile · 0 citations
Open access Sep 2026

Burden of atherosclerotic cardiovascular disease attributable to high body mass index, high fasting plasma glucose or high low density lipoprotein cholesterol in young and middle-aged adults from 1990 to 2050

This study aims to analyze the global burden of atherosclerotic cardiovascular disease (ASCVD) attributable to high low-density lipoprotein cholesterol (LDL-c), high body mass index (BMI), or high fasting plasma glucose (FPG) in young and middle-aged adults (15–49 years) from 1990 to 2021, with projections extending to...

Hua Zhang, Jun Li, Kai-Li Qin et al. · 0 citations
Sep 2026

[Association between novel high-density lipoprotein cholesterol metabolic phenotypes and all-cause and cardiovascular disease mortality in older adults in communities in Beijing].

These indicators can reveal metabolic heterogeneity and residual mortality risk which cannot be detected by traditional HDL-C concentration, suggesting their potential as auxiliary predictors for mortality risk and as tools for cardiovascular risk stratification and precision prevention in this population.

X.-X. Ye, Sheng-Yan Du, C.-X. Wang et al. · 0 citations
Open access Oct 2026

Cardiovascular risk among individuals with and without a genetic mutation for familial hypercholesterolemia: A long-term study.

BACKGROUND Patients with familial hypercholesterolemia (FH) are exposed to elevated low-density lipoprotein cholesterol (LDL-C) levels from early life. Whether FH independently increases risk of atherosclerotic cardiovascular disease (ASCVD) remains uncertain. OBJECTIVE To compare the risk of developing ASCVD between...

Ramus Laursen, E. Holck, H. Kanstrup et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.